CAMP and Venous thrombosis: The link between LL-37 and hypercoagulation was also tested in mice injected with the cathelicidins LL-37 and CRAMP, which presented increased occurrence of thrombosis, whereas deletion of the cathelicidin gene inhibited thrombosis in the animals (Duan et al., 2022).